Lupus (SLE)

Lupus is a chronic (long-lasting) autoimmune disease. Your immune system is normally your body's defence team: it attacks germs and keeps you healthy. In an autoimmune disease, that team gets confused and starts attacking your own healthy cells and tissues by mistake. This causes inflammation — swelling, heat and irritation — which over time can damage the parts of the body it affects.

The full medical name of the most common form is systemic lupus erythematosus, usually shortened to SLE or simply “lupus.” The word systemic means it can involve many different parts of the body rather than just one. Lupus most often affects the skin, joints and the kidneys, but it can also reach the blood, heart, lungs and brain.

One of the most distinctive things about lupus is that it tends to come and go. Periods when symptoms get worse are called flares, and quieter periods when symptoms ease or disappear are called remission. This unpredictable pattern is part of why lupus can be confusing to live with and why it sometimes takes time to recognise.

Lupus is not contagious — you cannot catch it from another person or pass it on. It is also not a single, fixed illness: it ranges from mild (mainly affecting skin and joints) to more serious forms that involve major organs. Most importantly, lupus today is a manageable condition. While there is no cure, the right combination of medicines and self-care helps the great majority of people keep it under control.

“Lupus” is an umbrella term for a few related conditions. Knowing which type you have matters, because they behave and are treated differently.

• Systemic lupus erythematosus (SLE) — the most common form, and the one most people mean when they say “lupus.” It can affect many organs and ranges from mild to severe.
• Cutaneous lupus erythematosus — lupus that mainly affects the skin. It causes rashes and sores, often on areas exposed to the sun. Some people have only skin involvement, while in others it is part of wider SLE. Two common patterns are discoid lupus (coin-shaped, scaly patches that can scar) and subacute cutaneous lupus (red, ring-shaped or scaly rashes triggered by sunlight).
• Drug-induced lupus — lupus-like symptoms triggered by certain prescription medicines. The good news is that symptoms usually fade once the medicine is stopped, under a doctor's guidance.
• Neonatal lupus — a rare, temporary condition in newborn babies, caused by certain antibodies passed from the mother during pregnancy. Most signs (such as a rash) clear up within about 6 months as those antibodies leave the baby's body. Rarely it can affect the baby's heartbeat, which is why pregnancies in mothers with specific antibodies are monitored closely.

A related condition often mentioned alongside lupus is lupus nephritis — this is not a separate type but the name for lupus inflammation affecting the kidneys. Because the kidneys are so important, lupus nephritis is taken seriously and treated promptly.

The honest answer is that researchers do not yet know exactly what causes lupus. It is not caused by anything you did wrong, and in most cases there is no single trigger to point to. Instead, experts believe lupus develops when several factors come together.

• Genetics. Certain genes can make a person more likely to develop lupus. Having a close relative with lupus slightly raises your risk — but most people with lupus have no family member with it, and most relatives of people with lupus never get it.
• Hormones. Because lupus is far more common in women of childbearing age, the hormone estrogen is thought to play a role, though the details are still being studied.
• Environment. Possible triggers in people who are already susceptible include sunlight (ultraviolet light), viral infections, smoking, and certain medicines. Stress is often reported around the time symptoms begin or flare.

Some groups are affected more often than others. Lupus is roughly nine times more common in women than in men, and most diagnoses happen between the ages of about 15 and 45. It is also more common, and sometimes more serious, among people of African, Caribbean, Hispanic/Latina, Asian, and Native American backgrounds. According to a US analysis funded by the Centers for Disease Control and Prevention, an estimated 204,295 Americans have SLE, with the highest rates among Black women. Worldwide, lupus advocacy groups estimate that several million people live with the condition. These figures describe populations, not any one person — lupus can affect anyone.

Lupus is sometimes called “the great imitator” because its symptoms overlap with many other conditions and vary a lot from person to person. You will not have all of these, and symptoms often come and go.

Common signs include:

• Extreme tiredness (fatigue) that does not improve with rest — one of the most common and disruptive symptoms.
• Joint and muscle pain, sometimes with swelling and morning stiffness.
• A “butterfly” rash (medically a malar rash) across the cheeks and bridge of the nose, often after sun exposure.
• Sensitivity to sunlight, where sun brings on rashes or makes you feel unwell.
• Other skin changes, hair loss, and painless mouth or nose sores.
• Fever with no obvious infection, and swollen glands.
• Raynaud's phenomenon — fingers or toes turning white, then blue, then red in the cold.
• Chest pain when breathing in, headaches, and low mood or anxiety.

You should see a doctor if you have unexplained, ongoing symptoms such as persistent fatigue, joint pain, a new rash (especially across the cheeks or triggered by sun), recurring fevers, or mouth sores — particularly if several of these occur together. Seek urgent medical care for warning signs of serious organ involvement, including significant swelling of the legs or around the eyes, blood in the urine or much less urine than usual, severe or unusual headaches, confusion, seizures, severe chest pain, or shortness of breath. These do not necessarily mean lupus, but they always deserve prompt assessment.

It is important to be clear: there is no routine screening test for lupus for the general public, in the way there is for some cancers. Because lupus is relatively uncommon and its symptoms overlap with many other conditions, doctors do not test everyone. Testing is done when a person has symptoms that suggest lupus might be present.

“Early detection” with lupus therefore means recognising the pattern of symptoms early and seeing a doctor, rather than catching it through a screening programme. This matters because starting treatment earlier in the disease course is linked to better outcomes and less long-term organ damage.

On average, lupus can take a frustratingly long time to diagnose — patient surveys suggest several years and frequent initial misdiagnosis — precisely because the symptoms are so varied and overlap with other illnesses. If you have been told your symptoms are “nothing” but they persist or worsen, it is reasonable to ask your doctor whether autoimmune conditions such as lupus have been considered, or to request a referral to a rheumatologist (a specialist in joints, muscles and autoimmune diseases). People already diagnosed with lupus are monitored regularly with blood and urine tests to catch flares and organ involvement early.

There is no single test that confirms lupus. Instead, doctors put together the picture from your symptoms, a physical examination, your medical history, and a combination of laboratory tests. Diagnosis often involves ruling out other conditions that can look similar.

The main blood tests include:

• Antinuclear antibody (ANA) test. This is the most sensitive screening test — almost everyone with SLE has a positive ANA. However, a positive ANA on its own does not prove lupus, because a small percentage of healthy people also test positive. It is a starting point, not a verdict.
• Anti-dsDNA and anti-Smith (anti-Sm) antibodies. These are much more specific to lupus. Anti-dsDNA can be linked to kidney involvement; anti-Sm is rarely seen in other conditions.
• Anti-Ro/SSA and anti-La/SSB antibodies. These are linked to sun sensitivity and are important in pregnancy planning because of the small risk to the baby's heart.
• Complement levels (C3, C4). These proteins can fall when lupus is active.
• Complete blood count, ESR/CRP, and urine tests. These check for anaemia, low blood cell counts, inflammation, and early signs of kidney involvement (protein or blood in the urine).

To bring consistency, specialists often refer to the 2019 EULAR/ACR classification criteria (developed by leading European and American rheumatology bodies). In this framework, a positive ANA is the required entry point, after which points are added for different clinical and laboratory findings. If the kidneys or skin appear involved, a doctor may recommend a biopsy — taking a tiny sample of tissue — to confirm the diagnosis and judge how active the disease is. A kidney biopsy also helps grade lupus nephritis, which guides treatment.

The aims of lupus treatment are to calm the overactive immune system, control symptoms, prevent flares, and protect the organs from long-term damage. Treatment is tailored to how severe your lupus is and which parts of the body are affected, so two people with lupus may be on quite different plans. There is no cure, but there are now more effective options than ever.

Medicines commonly used:

• Anti-inflammatory painkillers (NSAIDs), such as ibuprofen, for joint and muscle pain — used as advised, since long-term use needs medical supervision.
• Hydroxychloroquine, an antimalarial medicine that is a cornerstone of lupus care. It eases skin and joint symptoms and fatigue, helps prevent flares, and most people are encouraged to stay on it long term. It requires occasional eye checks.
• Corticosteroids (such as prednisolone), which reduce inflammation quickly. Doctors aim to use the lowest effective dose for the shortest time because of side effects.
• Immunosuppressants, which dampen the immune system — for example methotrexate, azathioprine, mycophenolate mofetil, or cyclophosphamide for more serious organ involvement such as lupus nephritis.
• Biologic and newer targeted medicines. These include belimumab (approved for SLE and for lupus nephritis), anifrolumab (for moderate-to-severe SLE), and voclosporin (used with other medicines for lupus nephritis). Rituximab is also used in some cases. These represent a genuine expansion of options in recent years.

Lupus is best managed by a multidisciplinary team led by a rheumatologist, working alongside, as needed, kidney specialists (nephrologists), skin specialists (dermatologists), heart and lung doctors, obstetricians for pregnancy, mental health support, and specialist nurses. Treatment also includes managing related risks, such as protecting bone health, blood pressure and heart health.

This is the question most people most want answered, so it deserves a careful, honest reply. The outlook for lupus has improved dramatically over the past few decades. Specialist sources report that, with modern treatment, the five-year survival rate is now over 90%, and that the great majority of people — commonly cited as around 80–90% — live more than ten years after diagnosis, with many living a normal or near-normal lifespan. For lupus affecting the kidneys (lupus nephritis), published cohorts report broadly similar long-term survival, especially when treatment starts early.

It is essential to understand what these numbers are and are not. They describe large groups of people studied in the past, not a prediction for any individual. Your own outlook depends on many things — which organs are involved, how early treatment begins, how the disease responds, other health conditions, and access to ongoing care. No statistic can tell you your personal future, and a number on a page cannot account for the steady improvements in treatment that continue today.

What most people can realistically expect is a long-term condition that is controlled rather than cured: periods of feeling well punctuated by occasional flares, kept in check by medicines, regular monitoring and self-care. Fatigue and the unpredictability can be genuinely hard, and emotional support is a normal part of good care. The single most important factor within reach is staying engaged with a specialist team and taking treatment as prescribed.

Living well with lupus is largely about a steady, long-term partnership with your care team and some practical habits that reduce flares.

• Keep your appointments and tests. Regular blood and urine tests catch problems — such as kidney involvement, anaemia or medicine side effects — before you notice symptoms. Do not stop medicines like hydroxychloroquine on your own, even when you feel well.
• Protect yourself from the sun. Because ultraviolet light can trigger flares, use a high-factor sunscreen (SPF 50+), wear hats and protective clothing, and be cautious in strong sun. Some people are also sensitive to certain bright indoor lighting.
• Pace yourself and manage fatigue. Balance activity with rest, prioritise sleep, and learn your early warning signs of a flare so you can act early.
• Stay active and eat well. Gentle, regular exercise (walking, swimming, yoga) helps joints, mood and heart health. A balanced diet, adequate vitamin D and calcium for bones, not smoking, and managing blood pressure all matter.
• Look after your mental health. Anxiety and low mood are common with any chronic illness. Counselling, support groups and talking openly with your team are part of treatment, not a sign of weakness.
• Plan pregnancy in advance. Lupus pregnancies are usually best timed for a period of good control and planned with a rheumatologist and obstetrician. Hydroxychloroquine is generally continued, and women with certain antibodies (anti-Ro/SSA, anti-La/SSB) have extra monitoring. With planning and specialist care, many women with lupus have healthy pregnancies.

Lupus is a long-term condition managed mainly with medicines and monitoring rather than a single operation, so when people travel for care it is usually to access specialist rheumatology assessment, a clear treatment plan, advanced testing, or newer therapies, with ongoing follow-up coordinated back home. Because of this, costs are highly individual, and we do not list prices here — we provide a personalised estimate after understanding your situation through a free consultation.

The main factors that affect cost include:

• How extensive your assessment needs to be (consultations, the range of blood and antibody tests, imaging, and whether a biopsy is required).
• Which organs are involved — for example, kidney involvement (lupus nephritis) usually means more tests and specialists.
• The medicines recommended, especially if newer biologic or targeted therapies are involved, which differ greatly in cost from standard tablets.
• Whether you need any inpatient stay versus outpatient (day) visits.
• The length and intensity of follow-up, and translation, coordination and travel logistics.

To prepare your records and get a more accurate estimate, gather: a summary letter from your current doctor; previous blood test and antibody results (including ANA, anti-dsDNA, complement levels); any urine test or kidney results; imaging and biopsy reports; a complete, up-to-date list of your medicines and doses; and a list of allergies. Translations into English are helpful. Sharing these in advance lets the specialist team review your case, advise whether travelling is sensible for you, and tailor a plan — and lets us give you a clear, personalised quote rather than a generic figure.

Turkiye has become a well-established destination for international patients, with a large number of internationally accredited hospitals, experienced specialists, modern laboratories and imaging, and dedicated international patient departments with multilingual coordinators. For a condition like lupus, the priority is not a procedure but the quality and continuity of specialist medical care — so choosing the right centre matters more than anything.

When choosing where to go, it is sensible to verify the following:

• Accreditation. Look for hospitals with recognised international accreditation such as JCI (Joint Commission International), which sets standards for patient safety and quality of care.
• A genuine rheumatology service and multidisciplinary team. Lupus care needs a qualified rheumatologist with access to nephrology, dermatology, and other specialists, plus a laboratory that can perform the full range of lupus antibody and monitoring tests.
• Specialist experience. Ask about the team's experience with lupus specifically, including lupus nephritis and the use of newer therapies where appropriate.
• Clear communication and continuity. Confirm that you will have an English-speaking coordinator, a written treatment plan and reports you can take home, and a clear arrangement for follow-up — ideally shared with your doctor in your home country.
• Honest, itemised information. A trustworthy centre will explain what is and is not included and give you a written estimate.

As a concierge service, our role is to help you compare suitable accredited centres, arrange the consultation, organise translations and logistics, and make sure your care is coordinated — without using pressure or making promises about outcomes, which no responsible provider can guarantee.

Because the exact cause of lupus is unknown, there is no proven way to prevent it from developing. What you can influence is the course of the disease once you have it — reducing flares and protecting your organs through consistent self-care and treatment.

Helpful, evidence-based steps include:

• Take your medicines as prescribed, especially hydroxychloroquine, and attend monitoring appointments.
• Protect your skin from the sun year-round.
• Do not smoke — smoking can worsen lupus and increases heart and blood-vessel risks that lupus already raises.
• Stay active, sleep well, manage stress, and eat a balanced diet with attention to bone and heart health.
• Keep vaccinations up to date as advised by your team, since some lupus treatments affect the immune system.
• Learn your personal flare triggers and early warning signs, and act on them early.

It is completely reasonable to seek a second opinion, particularly if your diagnosis is uncertain, your lupus is not responding to treatment, major organs are involved, or you are weighing newer therapies. A good specialist will welcome this. You may also ask your team whether any clinical trials — carefully regulated studies of new treatments — might be appropriate for you; lupus research is active, and trials are one route to emerging options. Above all, lupus is a condition to manage with, not without, expert support: an ongoing relationship with a qualified rheumatologist is the foundation of living well with it.